Sugammadex and oral contraceptives

Area of Science:

• Anesthesiology
• Pharmacology
• Reproductive Health

Background:

• Sugammadex is a reversal agent for neuromuscular blockade.
• Hormonal contraceptives are widely used by women of reproductive age.
• Potential drug interactions in the perioperative setting require careful consideration.

Purpose of the Study:

• To review current evidence on the interaction between sugammadex and hormonal contraceptives.
• To assess the clinical significance of sugammadex on contraceptive efficacy.
• To examine data from recent clinical trials and review articles.

Main Methods:

• Literature review of clinical trials and retrospective database studies.
• Analysis of reported cases of pregnancy in patients using hormonal contraceptives and sugammadex.
• Theoretical assessment of sugammadex's impact on different contraceptive methods.

Main Results:

• Current clinical data suggest sugammadex's interaction with estrogen and progesterone may not be clinically significant.
• No clinical trials specifically investigate sugammadex interactions with oral contraceptive pills.
• Two retrospective studies reported two cases of pregnancy in patients on hormonal contraceptives who received sugammadex.

Conclusions:

• There is a lack of strong clinical evidence to confirm or deny a significant impact of sugammadex on contraceptive efficacy.
• Existing evidence does not indicate a basis for concern regarding sugammadex's effect on contraception in the perioperative period.
• The method of contraception is a crucial factor to consider when evaluating potential interactions.